AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

XRTX · NASDAQ · Biotechnology

XORTX Therapeutics (XRTX)

Develops oral oxypurinol therapies for gout and kidney disease.

$2.42

At close+0.26 (+12.04%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

	Institutions1 holder · as of Mar 31, 2026	0.02%	9 ADS
	Otherremainder	99.98%	55.7K ADS

55.7K ADS (1 ADS = 25 ordinary shares) as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (55.7K in the company's Sep 3, 2026 report, 278.5K elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
TD Waterhouse Canada Inc.Institution	0.02%	47 ADS	13Fas of Mar 31, 2026
Armistice Capital, LLCStrategic	—9.99% of class, as filed	—	13D/Gfiled Feb 14, 2023 ↗
Lincoln Alternative Strategies LLCStrategic	—9.90% of class, as filed	—	13Gfiled Oct 27, 2025 ↗

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more

Institutions13F, as of Mar 31, 2026

1 holder · 47 shares · 1 new position · 1 increased · 0 reduced · 6 closed

Holder	Shares	% outstanding	Chg q/q	Filed
TD Waterhouse Canada Inc.	47	0.08%	+47new	May 12, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Lincoln Alternative Strategies LLC	9.90%		13G	Oct 27, 2025 ↗

XORTX Therapeutics (XRTX)

Breakdown13F · 13D/G · Form 4

Top shareholders13F · 13D/G · Form 4

Institutions13F, as of Mar 31, 2026

Ownership statements13D/G · 5% or more, as filed

Insider tradesForm 4

Latest trades

CongressHouse and Senate disclosures